Don Husereau : Citation Profile


Are you Don Husereau?

4

H index

2

i10 index

304

Citations

RESEARCH PRODUCTION:

20

Articles

RESEARCH ACTIVITY:

   11 years (2013 - 2024). See details.
   Cites by year: 27
   Journals where Don Husereau has often published
   Relations with other researchers
   Recent citing documents: 14.    Total self citations: 7 (2.25 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/phu379
   Updated: 2024-11-04    RAS profile: 2024-03-17    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Don Husereau.

Is cited by:

Gerdtham, Ulf-G. (4)

Leidl, Reiner (3)

Miguel, Edward (3)

Vass, Caroline (2)

Leidl, Reiner (2)

Campbell, Julie (1)

Kern, Axel (1)

Frey, Simon (1)

Polyakova, Maria (1)

Han, Euna (1)

Viney, Rosalie (1)

Cites to:

Docteur, Elizabeth (6)

Gray, Alastair (4)

Froud, Robert (4)

Brazier, John (3)

Lakdawalla, Darius (2)

Philipson, Tomas (2)

Feeny, David (2)

Yin, Wesley (2)

Goldman, Dana (2)

Devlin, Nancy (1)

Fernandez, Jose Luis (1)

Main data


Where Don Husereau has published?


Journals with more than one article published# docs
Applied Health Economics and Health Policy6
PharmacoEconomics5
PLOS ONE3
The European Journal of Health Economics3
Medical Decision Making2

Recent works citing Don Husereau (2024 and 2023)


YearTitle of citing document
2024Evaluation of the public policy impacts on Monkeypox in Brazil. (2024). Oliveira, Angelo Marcio ; de Melo, Carlos Jefferson. In: Evaluation and Program Planning. RePEc:eee:epplan:v:103:y:2024:i:c:s0149718924000156.

Full description at Econpapers || Download paper

2024Policy implications of heterogeneous demand reactions to changes in cost-sharing: Patient-level evidence from Austria. (2024). Czypionka, Thomas ; Six, Eva ; Berger, Michael. In: Social Science & Medicine. RePEc:eee:socmed:v:340:y:2024:i:c:s0277953623008456.

Full description at Econpapers || Download paper

2023Exploring the effectiveness of demand-side retail pharmaceutical expenditure reforms: cross-country evidence from weighted-average least squares estimation. (2022). Czypionka, Thomas ; Rohrling, Gerald ; Reiss, Miriam ; Pock, Markus ; Berger, Michael. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:116928.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review. (2023). Haines, Terry ; Truby, Helen ; Mortimer, Duncan ; Shersher, Violetta ; Gallagher, Andrew. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:2:d:10.1007_s40258-022-00759-4.

Full description at Econpapers || Download paper

2023Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands. (2023). Postma, A J ; Quist, S W ; Jong, L A ; Myren, K J. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:9:d:10.1007_s10198-022-01556-5.

Full description at Econpapers || Download paper

2023Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran. (2023). Jafari, Abdosaleh ; Hajahmadi, Marjan ; Jalali, Farideh Sadat ; Ravangard, Ramin. In: Health Economics Review. RePEc:spr:hecrev:v:13:y:2023:i:1:d:10.1186_s13561-023-00457-4.

Full description at Econpapers || Download paper

2023Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review. (2023). Gafos, Mitzy ; Quaife, Matthew ; Terris-Prestholt, Fern ; Bozzani, Fiammetta M ; Torres-Rueda, Sergio ; Malhotra, Shelly ; Medley, Graham F ; Giddings, Rebecca ; Indravudh, Pitchaya P. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:5:d:10.1007_s40273-022-01223-w.

Full description at Econpapers || Download paper

Works by Don Husereau:


YearTitleTypeCited
2013Capturing Value from Health Technologies in Lean Times In: C.D. Howe Institute Commentary.
[Full Text][Citation analysis]
article2
2014A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development In: PLOS ONE.
[Full Text][Citation analysis]
article11
2018Economic evaluations of eHealth technologies: A systematic review In: PLOS ONE.
[Full Text][Citation analysis]
article4
2020Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis In: PLOS ONE.
[Full Text][Citation analysis]
article0
2019Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB) In: Medical Decision Making.
[Full Text][Citation analysis]
article0
2024Reporting Economic Evaluations with Value of Information Analyses Using the CHEERS Value of Information (CHEERS-VOI) Reporting Guideline In: Medical Decision Making.
[Full Text][Citation analysis]
article0
2015How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States? In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article1
2016Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2018Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2020Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2022Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article6
2022Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.(2022) In: The European Journal of Health Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6
article
2022Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.(2022) In: PharmacoEconomics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6
article
2022Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article1
2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article279
2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement.(2013) In: PharmacoEconomics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 279
article
2021Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2015Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2018Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2021Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT) In: PharmacoEconomics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team